Clinical trial in France leaves six ill, one brain-dead
Clinical trial in France leaves six ill, one brain-dead

Clinical trial in France leaves six ill, one brain-dead

One person has been left brain dead and five others are in a serious condition after taking part in a clinical trial in France of an experimental medicine allegedly for a dagga (cannabis) based painkiller.

The six patients were in good health until taking the oral medication in Rennes, north-west France, wrote the French Health Minister Marisol Touraine in a statement according to AFP.

She said on Friday that “a serious accident took place,” which has resulted in the study being halted and all volunteers taking part recalled.

According to the Guardian, Touraine also said that the patients were admitted to hospital at the beginning of this week and six people had taken part in the trial that was being developed by a European laboratory .

While the intended use for the new medicine is unknown, a source told AFP that the drug was a painkiller containing an active ingredient found in cannabis plants, cannabinoids.

The French state prosecutor has opened an inquiry and all trials on the unnamed drug in the clinic has been suspended.

Agencies/Canadajournal




  • About News

    Web articles – via partners/network co-ordinators. This website and its contents are the exclusive property of ANGA Media Corporation . We appreciate your feedback and respond to every request. Please fill in the form or send us email to: [email protected]

    Check Also

    Brian Laundrie news: 'We're not wasting our time,' police commander says

    Brian Laundrie news: ‘We’re not wasting our time,’ police commander says

    VENICE, Fla. – Six days into the search for Brian Laundrie, police in North Port …

    Leave a Reply